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Abstract
Background: Although reduced function of the respiratory system limits peak oxygen uptake in diseases affecting
the lungs or airways, the healthy respiratory system is thought to have a spare capacity for oxygen transport and
uptake, and is not considered a limiting factor for peak oxygen uptake in healthy people. However, lung function
declines with age and could theoretically limit peak oxygen uptake in elderly. We examined the association
between peak oxygen uptake and lung function indices in an elderly population with the hypothesis that lung
function indices would be associated with VO2peak up to a threshold value situated above the lower limits of
normal lung function for our population.
Methods: Spirometry, gas diffusion tests and incremental work tests were performed in 1443 subjects (714 women) aged
69–77 years. Association between lung function indices and peak oxygen uptake was studied with hockey-stick regression.
Results: Forced expiratory volume in 1 s (FEV1) had a positive association with peak oxygen uptake up to, but not above, a
threshold value of 2.86 l for men, and 2.13 l for women (lower limit of normal 2.73 and 1.77 l respectively).
A corresponding threshold was found for diffusing capacity of the lung for carbon monoxide (DLCO) for men at 9.18 mmol/
min/kPa (lower limit of normal 6.84 mmol/min/kPa). DLCO for women and DLCO divided by alveolar volume (DLCO/VA) for
both sexes had a significant linear relationship to VO2peak (p< 0.05), but no significant threshold value was found in these
associations.
Conclusions: Threshold values for FEV1 for both sexes and DLCO for men were identified. These lung function indices had a
positive association with VO2peak up to these threshold values, but not above. The identified threshold values were above
lower limits of normal for FEV1 and DLCO.
Keywords: Exercise and lung function, Respiratory physiology, Ageing
Background
It is generally accepted that maximal cardiac output is
the principal limiting factor for peak oxygen uptake
(VO2peak) in healthy individuals exercising at sea-level.
By contrast the respiratory system has been considered
to be structurally overbuilt both with respect to dynamic
lung function and diffusion capacity, and is therefore
believed not to restrict oxygen uptake even during
maximal exercise in non-endurance athletes [1, 2].
Reduced lung function limits VO2peak in patients with
pulmonary disease [3–7], but the association with VO2peak
for lung function indices within the normal range is little
studied.
In healthy ageing there is a steady decline of dynamic
lung volumes. Expiratory flow is reduced and the flow-
volume curve may resemble what is found in patients
with chronic obstructive pulmonary disease [8]. The
capacity of the lung for gas diffusion is also reduced with
age [9]. Elderly have an increased dead space to tidal vol-
ume ventilation ratio compared to younger individuals
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and develop a marked alveolar to arterial oxygen gra-
dient during exercise [10]. The spare capacity of the
respiratory system is possibly reduced in elderly com-
pared to middle-aged and young people, and both dy-
namic lung function and the diffusion capacity of the
lungs may therefore be associated with reduced oxy-
gen uptake even in healthy elderly people. This has
previously not been examined in population based
studies.
Given that the healthy respiratory system is overbuilt
with respect to requirements for oxygen uptake, one
would observe an association between lung function and
VO2peak only when the capacity of the respiratory system
is reduced below a threshold value which is below the
lower limits of normal lung function. However, if the
spare capacity of lung function is reduced with in-
creasing age, this threshold may be found within the
range of normal lung function in an elderly population,
in that case suggesting that VO2peak may be limited by
lung function in many healthy elderly. The present
study examined the association between VO2peak and
parameters from spirometry and gas diffusion tests in
a large population based sample of elderly men and
women.
We wanted to investigate if lung function indices were
associated with VO2peak up to a threshold value above
which further increase in lung function would not be as-
sociated with increasing VO2peak. If a threshold value
were identified, we hypothesized that this threshold
would be above the LLN (lower limits of normal) for
lung function, i.e. within the normal range of lung func-
tion for this population.
Methods
Study population
The ongoing Generation 100 Study invited all inhabi-
tants in the city of Trondheim, Norway, born between
01 January 1936 and 31 December 1942 (n = 6966) to a
randomized controlled trial on the effect of exercise
intervention on morbidity and mortality in an ageing
population [11]. Study subjects were included from
August 2012 to June 2013 giving a study population aged
69–77 years. The present study includes baseline data of
participants that were able to perform exercise testing and
training. Participants with chronic communicable infec-
tious diseases, dementia, uncontrolled hypertension, heart
failure, cardiomyopathy, severe arrhythmia, participating
in other studies conflicting with Generation 100, or
with conditions or test results indicating that testing
or training could be unsafe were excluded. The Gen-
eration 100 Study and the present sub-study were ap-
proved by the Regional Committee for Medical Research
Ethics (REK 2012/381 B) and all participants gave written
informed consents.
Examinations
A symptom-limited incremental work test on a treadmill
was performed to measure VO2peak using MetaMax II
(Cortex, Leipzig, Germany) or Oxycon Pro (Erich Jaeger,
Hoechberg, Germany) as previously described [12]. Par-
ticipants not able to perform the test on a treadmill due
to poor balance or other reasons performed the test on a
cycle ergometer. Load was increased 1 km/h or 2 % in-
clination on the treadmill approximately every 90 s until
exhaustion, on the bicycle load was increased 10 W
every 30 s. Testing of participants with suspected or pre-
viously diagnosed heart disease was supervised by a
trained physician [13]. For simplicity the term VO2peak is
used throughout this paper, even when referring to work
by others that have reported maximum oxygen uptake.
The participants reported average physical activity by
answering three questions covering frequency, intensity
and duration of physical activity. The answers were
given different weights and a physical activity index was
calculated as previously described [14].
Spirometry and gas diffusion test were performed
with Sensormedics Vmax22 Encore (CareFusion, San
Diego, USA) in accordance with the American Thor-
acic Society/European Respiratory Society recommen-
dations [15, 16]. The spirometer was calibrated daily.
The study participants performed up to a maximum
of eight spirometry trials until forced expiratory vol-
ume at 1 s (FEV1) and forced vital capacity (FVC)
showed <150 ml variation between the two highest
results. The highest values for vital capacity (forced
expiratory or inspiratory) and FEV1 were recorded.
No reversibility test was performed. For the day of testing,
participants were instructed to continue any medication
as usual, including anti-obstructive treatment. Predicted
values and lower limit of normal (LLN) were calculated
from Norwegian reference equations using age, sex and
height [17].
Diffusing capacity of the lung for carbon monoxide
(DLCO) was measured by the single breath-method using
a gas mixture containing 0.3 % carbon monoxide and
0.3 % methane. Estimated alveolar volume (VA) was cal-
culated based on the dilution of methane from inspired
to expired gas. The procedure was repeated with at least
4 min between each trial up to a maximum of 4 trials,
until two tests of acceptable quality show DLCO within
1 mmol/min/kPa or within 10 % of the highest value
and the mean of these values were recorded. Predicted
values were calculated using equations developed for a
comparable age group [18].
The spirometry and DLCO-test were administered by
a pulmonary care nurse or medical doctor and all
measurements were quality controlled.
Body-fat percentage was measured with bioelectric
impedance analysis (Inbody 720, Seoul, South Korea). In
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addition to the clinical tests, the participants filled out
health-related questionnaires.
Statistics
All analyses were stratified by sex. A statistical proced-
ure called hockey-stick regression was applied [19]. It as-
sumes that the effect of variable x is best fitted by two
continuous linear functions; the slopes of both lines and
also the change-point where the two lines meet are esti-
mated. The resulting combined fitted line has one slope
up to a change-point on the x-axis and a different slope
after the change-point. Hockey-stick regressions with
VO2peak (ml/min/kg) as the dependent variable were per-
formed; FEV1, DLCO and DLCO adjusted for alveolar vol-
ume (DLCO/VA) were tested as variables with change-
points in separate models. For comparison linear and
curvilinear models were also fitted. In the linear models
FEV1, DLCO and DLCO/VA were added as linear vari-
ables; and in the curvilinear models these measurements
were added as both linear and squared variables. The
analyses were controlled for age, physical activity index,
resting heart rate and body-fat percentage, smoking sta-
tus and self-reported heart disease. Covariates were
chosen based on previous prediction models for VO2peak
[14, 20]; self-reported heart disease was also added due
to potential confounding in this age group. Control vari-
ables were continuous linear variables, except for
current smoking (coded 1 or 0) and self-reported heart
disease coded 1 for self-reported history of myocardial
infarction, angina pectoris or atrial fibrillation, otherwise
0. Chow test with null-hypothesis that intercept and co-
efficient are equal before and after change point were
used to test for structural break at change-point, and f-
test were used to compare hockey-stick and curvilinear
models to linear models. All calculations were per-
formed with Stata 13.1 (StataCorp, Texas, USA); hockey-
stick regressions were modelled with the “nl hockey”
function.
Results
A total number of 1567 VO2peak-tests were completed;
of these 47 on a cycle ergometer. Forty cases were omitted
from the analyses due to submaximal effort (maximal self-
reported value <15 on the 6-20 Borg scale); and 84 were
omitted due to missing physical activity score, smoking
status, body-fat percentage or valid spirometry data. De-
scriptive statistics for the 1443 participants included in the
analyses are shown in Table 1, histograms showing the
distribution of VO2peak, FEV1 and DLCO and DLCO/VA are
shown in Additional file 1.
Significant change-points in the association with
VO2peak were found for FEV1 for men at 2.86 l (LLN =
2.73 l) and for women at 2.13 l (LLN = 1.77 l) (Table 2).
The association between FEV1 and VO2peak was positive
up to these values, but not above. The change-points
correspond to the 31st and 28th percentile of mea-
sured FEV1, for men and women respectively. A
change-point was also found in the association be-
tween DLCO and VO2peak for men at 9.18 mmol/min/kPa
(LLN= 6.84 mmol/min/kPa), corresponding to the 54th
percentile. No significant change-point in the association
between DLCO and VO2peak was found for women. Fur-
thermore, no significant change-points were found in the
association between DLCO/VA and VO2peak for either sex.
Predicted effect plots for these hockey-stick regression
models are shown in Fig. 1.
Explained variance (adjusted R2) for VO2peak from the
hockey stick models were compared to corresponding





Age 72.8 ± 2.1 72.9 ± 2.1
Height (cm) 176.9 ± 5.9 163.4 ± 5.3
Weight (kg) 82.5 ± 11.3 68.4 ± 10.9
Body mass index (kg/cm2) 26.3 ± 3.2 25.6 ± 3.8
Body-fat percentage 25.5 ± 6.3 34.7 ± 7.0
Resting heart rate (beats per minute) 62.7 ± 11.2 66.8 ± 10.0
Physical activity index 9.3 ± 8.6 8.0 ± 8.7
Self-reported heart disease (% yes)
(MI, angina or atrial fibrillation)
18.6 % 5.5 %




10.8 % 12.5 %
Smoking status:
Never 41.5 % 54.2 %
Former 50.5 % 37.4 %
Current 7.9 % 8.4 %
Pack years 8.2 ± 14.2 4.9 ± 10.5
FEV1 (litres) 3.13 ± 0.60 2.24 ± 0.37
FEV1 % of predicted 94.0 ± 16.7 102.4 ± 15.9
FEV1/FVC (%) 72.1 ± 8.1 73.4 ± 6.6
DLCO (mmol/min/kPa) 9.04 ± 1.68 6.73 ± 1.14
DLCO % of predicted 93.5 ± 16.0 86.3 ± 13.5
DLCO/VA (mmol/min/kPa/l) 1.37 ± 0.22 1.40 ± 0.20
DLCO/VA % of predicted 93.7 ± 18.2 84.8 ± 11.9
Peak oxygen uptake (ml/min/kg) 31.3 ± 6.7 26.1 ± 5.0
Respiratory Exchange Ratio at peak work 1.14 ± 0.09 1.10 ± 0.09
Peak heart rate (bpm) 156.7 ± 17.7 156.5 ± 15.9
Ventilation at peak exercise (litres) 96.4 ± 21.2 61.2 ± 12.5
Definition of abbreviations: MI =myocardial infarction; FEV1 = forced expiratory
volume in 1 s; FEV1/FVC = FEV1 divided by forced vital capacity; DLCO – diffusing
capacity of the lung for carbon monoxide; DLCO/VA – DLCO corrected for
estimated alveolar volume. Values are given as percentage or mean ± standard
deviation
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linear and curvilinear models (Table 3). For the associ-
ation between FEV1 and VO2peak the hockey-stick model
gave higher R2-values than the linear and curvilinear
models (R2 = 0.433 (hockey-stick) vs. 0.423 (linear) and
0.429 (curvilinear) for men, and R2 = 0.460 (hockey-stick)
vs. 0.452 (linear) and 0.456 (curvilinear) for women), sup-
porting the choice of statistical model for this relationship.
For DLCO the hockey-stick model was significantly better
than the linear model for men (R2 = 0.450 vs. 0.440), but
not for women (R2 = 0.470 vs. 0.469); and for both sexes
R2-values from hockey-stick model were similar to R2
from curvilinear models (Table 3). For DLCO for women
and for DLCO/VA for either sex, neither the hockey stick
model nor the curvilinear model was significantly better
than the linear model, suggesting linear relationships. Full
descriptions of models are presented in Additional file 2.
To evaluate the effects of self-reported physical activity
on the identified change-points, sub-group analyses were
performed separately on those reporting high physical
activity (physical activity index > = 15) and those reporting
low activity (physical activity index < 15). A physical activ-
ity index score of 15 corresponds to reporting exercise
once a week with high intensity and duration >30 min; or
exercise 2–3 times per week with moderate intensity and
duration >30 min; or exercise almost every day of
moderate intensity and duration <30 min. This cut-
point classifies 50.2 % of men and 44.7 % of women
as reporting high physical activity. For men change-
points for FEV1 were 2.90 l for those reporting high
physical activity (LLN = 2.75 l) and 2.68 l for those
reporting low activity (LLN = 2.73 l); the corresponding
change-point localizations for DLCO were 11.0 mmol/min/
kPa for high activity (LLN= 6.82 mmol/min/kPa) and
7.13 mmol/min/kPa for low activity (LLN= 6.85 mmol/
min/kPa). For corresponding sub-groups of women the
change-point values for FEV1 were 2.13 l for high activity
(LLN= 1.78 l) and 2.12 l for low activity (LLN= 1.77 l).
To assess the effect of lung disease in our analyses, self-
reported pulmonary disease (history of asthma, chronic
bronchitis, emphysema or chronic obstructive pulmonary
disease) were tested as an independent variable in the re-
gression analyses. Self-reported pulmonary disease was
not a significant predictor for VO2peak in the hockey-stick
model for FEV1 for either sex, and did not increase R
2 or
affect the identified threshold value. In the hockey-stick
model for DLCO for men, self-reported pulmonary disease
was a significant predictor for VO2peak, but had only a
minimal effect on the value, which decrease from 9.18 to
9.07 mmol/min/kPa.
Discussion
In this large population sample we have found evidence
for a change-point in the association with VO2peak for
FEV1 and DLCO in men and FEV1 in women. The associa-
tions between these variables and VO2peak were significant
up to the change-points, but no significant associations
were found above these values. This suggests that there
may be a physiologic threshold for these lung function pa-
rameters, above which the lung function does not limit
VO2peak. The identified threshold values are within the
normal limits of lung function for this age group, which
may suggest that lung function can be a limiting factor for
maximal physical performance for many healthy elderly. A
linear association with VO2peak was found for DLCO for
women and DLCO/VA for both sexes, but no significant
threshold was found for these parameters.
The identified change-points for FEV1 equals 86 % of
predicted for men and 97 % for women when age and
height are set to sample means; and are higher than
calculated LLN at 2.73 l for men and 1.77 l for women.
Predicted values and LLN were calculated using relevant
Norwegian reference equations [17]. If instead using the
2012 Global Lung Function Initiative equations [21] the
change-points would be 93 % of predicted FEV1 for men
and 99 % for women, so using the Norwegian reference
values is the more conservative approach. The threshold
for DLCO for men corresponds to 95 % of predicted
and is higher than LLN at 6.84 mmol/min/kPa. For the
Table 2 Change-point regression for association with peak oxygen uptake (ml O2/min/kg)
Change point (95 % CI) Left slope (95 % CI) Right slope (95 % CI)
Men:
FEV1 (n = 729) 2.86 litres* (2.54, 3.17) 4.58† (2.85, 6.31) 0.60 (-0.56, 1.75)
DLCO (n = 712) 9.18 mmol/min/kPa* (8.32, 10.05) 1.57† (1.06, 2.07) 0.16 (-0.37, 0.68)
DLCO/VA (n = 712) 1.36 mmol/min/kPa/l (0.99, 1.74) 8.54† (4.32, 12.75) 4.99† (0.89, 9.08)
Women:
FEV1 (n = 714) 2.13 litres * (1.93, 2.34) 3.76† (1.60, 5.92) −0.84 (-2.22, 0.55)
DLCO (n = 697) 5.50 mmol/min/kPa (4.45, 6.56) 1.54 (-0.04, 3.12) 0.31 (-0.01, 0.62)
DLCO/VA (n = 697) 1.43 mmol/min/kPa/l (1.18, 1.68) 5.14† (2.37, 7.91) 1.25 (-2.30, 4.80)
Definition of abbreviations: FEV1 = forced expiratory volume in 1 s; DLCO – diffusing capacity of the lung for carbon monoxide; DLCO/VA – DLCO corrected for
estimated alveolar volume. Non-linear “Hockey-stick” regressions for the associations between pulmonary function variables and peak oxygen uptake. * p < 0.01
for hockey-stick model vs. linear model (f-test), † p < 0.01 for slope being different from 0
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association between DLCO and VO2peak in women, neither
the hockey-stick model nor the curvilinear model perfor-
med better than the multiple linear model; which may
either be due to physiologic differences between sexes or
to lack of statistical power to detect a levelling off of this
relationship in women.
Several studies have shown that VO2peak is reduced in
patients with lung disease and reduced lung function
Fig. 1 Predicted effect plots for hockey-stick models. In separate models forced expiratory volume in 1 s (FEV1) in litres, diffusing capacity of the
lung for carbon monoxide (DLCO) in mmol/min/kPa and DLCO corrected for estimated alveolar volume (DLCO/VA) in mmol/min/kPa/l were added
as variables with change points. Dependent variable is peak oxygen uptake in ml/min/kg. All models included age, self-reported physical activity,
resting heart rate, body-fat percentage, self-reported history of heart disease and current smoking status as control variables. To illustrate the
isolated effect of the lung function parameters, control variables were set to sample mean for these plots. Vertical lines mark change-points;
dashed lines mark lower limit of normal; grey fields mark 95 % confidence interval for slopes; dots mark observations. Change-points were significant
(p < 0.5) for FEV1 for both sexes and for DLCO for men, but not for DLCO for women and DLCO/VA for neither sex
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[3–6], but there are few studies on the relationship be-
tween pulmonary function measurements and VO2peak
in healthy subjects. Babb et al. [22] reported a significant
linear relationship between FEV1 and VO2peak in a small
sample of asymptomatic volunteers selected to have a
wide range of FEV1 (n = 11, age = 58 ± 8 years). Johnson
et al. [23, 24] studying a group of active healthy older
subjects (n = 30, age = 70 ± 1 years) found a correlation
between % of predicted DLCO and VO2peak, and also
showed that FEV1 were significantly higher in subjects
with VO2peak above the median compared to those with
VO2peak below the median. These studies had few partic-
ipants and were not designed to study the association
between lung function indices and VO2peak, and they do
not allow general conclusions about this association. On
the other hand, in an interventional study, Sue-Chu
et al. [25] examined the effect of the bronchodilator
salbutamol on VO2peak in non-asthmatic highly-trained
cross-country skiers with high VO2peak. These subjects
did not improve the VO2peak in spite of a significant im-
provement in FEV1, suggesting that even highly trained
endurance athletes are not usually ventilatory limited
with respect to VO2peak. A significant proportion of
highly fit endurance athletes develops arterial hypoxemia
during sub-maximal or maximal exercise [26]. This
exercise-induced arterial hypoxemia limits VO2peak and
this limitation can be reversed by supplemental oxygen
during exercise [27, 28], suggesting that diffusion cap-
acity could be a limiting factor in these subjects.
Physical exercise improves the capacity of the cardio-
vascular and locomotor systems to transport and utilize
oxygen, while no such effect is evident on the respiratory
system. An improvement in the maximal function of the
circulatory and muscular systems from exercise would
therefore increase the demand on the respiratory system
for oxygen transport, reducing any spare capacity of this
system. We would therefore expect that the association
between lung function indices and VO2peak would be sig-
nificant up to higher levels of FEV1 and DLCO in an
exercise-trained population compared to a more sedate
one. This is in accordance with the sub-group analyses
in our study showing change-points at higher levels of
lung function in men with high self-reported physical
activity compared to low self-reported activity. This effect
is particularly pronounced for the association between
DLCO and VO2peak, suggesting that DLCO may represent a
limiting factor for exercise capacity for men in this age
group. For women, the location of the change point in the
association between FEV1 and VO2peak is almost identical
for those reporting high vs. low physical activity (2.13 vs.
2.12 l).
The findings in our study may be due to the age-
related changes in the lung function of elderly people.
With increasing age the lungs loose elastic recoil, the
thorax wall gets stiffer and more restricted, respiratory
muscle function is impaired, the alveolar surface area is
reduced and there is increased ventilation-perfusion het-
erogeneity [29]. These changes cause expiratory flow
limitation and reduced gas diffusion capacity in elderly
compared to younger subjects. Even though there is a
decline in the capacity for ventilation and gas exchange
with age, there is also an age-related decline in the cap-
acity of the other links of the oxygen uptake chain thus
reducing the demands on the respiratory system. The
margin between demand and capacity in the respiratory
system decreases with age, but limitation of VO2peak due
to demands exceeding the capacity is thought to be rare
[30]. Our findings of an association with VO2peak for
FEV1 and DLCO in the lower reference area may suggest
that a reduced capacity of the respiratory system may be
limiting for VO2peak for many elderly. The spare capacity
of the lungs and airways seen in young healthy subjects
may be fully eroded in many elderly, resulting in a limita-
tion of VO2peak and maximal work rate by the respiratory
system for these individuals.
The main strength of the present study is the
population-based design and high number of subjects
with directly measured VO2peak combined with spirom-
etry and gas diffusion testing. To our knowledge, there
are no other large studies examining the association
between normal lung function and VO2peak. Even
though known or plausible confounders were controlled
for in our analyses, there might still be some residual
confounding. Unrecognized pulmonary disease may con-
tribute to residual confounding, but since pulmonary
Table 3 Explained variance of VO2peak (Adjusted R
2) of models
with and without change points
Added variable Hockey-stick model Linear model Curvilinear model
Men:
FEV1 0.433* 0.423 0.429*
DLCO 0.450* 0.440 0.451*
DLCO/VA 0.440 0.441 0.441
Women:
FEV1 0.460* 0.452 0.456*
DLCO 0.470 0.469 0.470
DLCO/VA 0.477 0.476 0.477
Definition of abbreviations: VO2peak = peak oxygen uptake; FEV1 = forced
expiratory volume in 1 s; DLCO – diffusing capacity of the lung for carbon
monoxide; DLCO/VA – DLCO corrected for estimated alveolar volume. Resulting
explained variance (Adjusted R2) of regression models with peak oxygen
uptake as dependent variable with variable in first column added either as a
variable with change point, as a linear variable or as a curvilinear variable
(both variable and variable2). Age, self-reported physical activity, resting heart
rate, body-fat percentage, self-reported history of heart disease and current
smoking status are control variables in all models. *P-value < 0.05 for R2-
change compared to linear model (f-test). Adjusted R2 for VO2peak in a multiple
linear model without pulmonary function measurements, including only age,
physical activity index, resting heart rate, body-fat percentage, smoking status
and heart disease history were 0.393 for men and 0.448 for women
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function is already included in the analyses, pulmonary
disease would have to affect VO2peak independently of
pulmonary function if pulmonary disease were to be a
confounder for this relationship. We cannot test whether
unrecognized pulmonary disease affects the results, but
we can test this for those with self-reported pulmonary
disease. Self-reported pulmonary disease is a significant
predictor of VO2peak only when FEV1 is not included in
the analyses, indicating that pulmonary disease is an up-
stream variable of FEV1, and therefore not a relevant con-
founder in the analyses. Even though we have identified
threshold levels in the associations between lung function
indices and VO2peak on the population level for our sub-
jects, the thresholds cannot be assumed to apply to indi-
vidual subjects. Neither can we conclude that a subject
having lung function below the threshold values has a
pulmonary limitation of VO2peak. The physiologic basis for
the observed change-point in the association between lung
function indices and VO2peak may be age specific, and it
cannot be assumed that the results in this study apply
to younger or middle-aged populations. Ventilation-
perfusion heterogeneity and widened alveolar-arterial
oxygen pressure gradient are likely to be important
factors for the limiting effect of the respiratory system
on VO2peak; and measurements of blood oxygen concen-
tration during exercise would likely have yielded further
knowledge on this topic. Participants in this study were
recruited to an exercise intervention study, and may be
habitually physically active or at least more interested in
exercise than the general population. This is a descriptive
study with a cross-sectional design and it does not allow
for conclusions on causality, and the results should there-
fore be interpreted with caution.
Conclusions
We have found evidence of a threshold in the associ-
ation between lung function measurements and VO2peak
in this elderly population. FEV1 for both sexes and for
DLCO for men were positively associated with VO2peak
only up to these threshold values. The identified thresh-
old values are well within the normal range for these
lung function parameters. DLCO for women and DLCO/
VA for both sexes were linearly associated with VO2peak.
A possible explanation for our findings could be that
lung function even within the normal range may be a
limiting factor for maximal oxygen uptake for many
elderly.
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